What is Healshape?
Healshape, established in January 2020 in Lyon, France, is a regenerative medicine biotechnology startup. Founded by six associates, the company is focused on developing innovative solutions within the rapidly evolving field of medical regeneration. Its creation in early 2020 places it within a period of significant advancement and investment in biotech and healthcare technologies.
How much funding has Healshape raised?
Healshape has raised a total of $6.8M across 1 funding round:
Series A
$6.8M
Series A (2022): $6.8M with participation from Pulsalys SAS
Key Investors in Healshape
Pulsalys SAS
Pulsalys SAS is an investment entity that participated in Healshape's Series A funding round. Further details on their specific investment focus are not provided.
What's next for Healshape?
With the recent major strategic investment, Healshape is poised for accelerated development and market penetration. This enterprise-level funding is expected to fuel advancements in its regenerative medicine technologies, potentially leading to expanded clinical trials, product development, and strategic partnerships. The company's trajectory suggests a focus on scaling its operations and solidifying its position as a key player in the biotech industry, leveraging this capital for innovation and growth.
See full Healshape company page
